These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 15702434)
1. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes. Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434 [TBL] [Abstract][Full Text] [Related]
2. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198 [TBL] [Abstract][Full Text] [Related]
3. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes. Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490 [TBL] [Abstract][Full Text] [Related]
4. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729 [TBL] [Abstract][Full Text] [Related]
5. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
7. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate. Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586 [TBL] [Abstract][Full Text] [Related]
9. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209 [TBL] [Abstract][Full Text] [Related]
12. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677 [TBL] [Abstract][Full Text] [Related]
13. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. Gao L; Yu DM Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171 [TBL] [Abstract][Full Text] [Related]
16. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556 [TBL] [Abstract][Full Text] [Related]
17. Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Flyvbjerg A; Schrijvers BF; De Vriese AS; Tilton RG; Rasch R Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E362-6. PubMed ID: 12110543 [TBL] [Abstract][Full Text] [Related]
18. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model. Jesmin S; Sakuma I; Hattori Y; Fujii S; Kitabatake A Diabetologia; 2002 Mar; 45(3):402-15. PubMed ID: 11914746 [TBL] [Abstract][Full Text] [Related]
19. [Expression of VEGF in kidney of diabetic rats]. Chen ZJ; Yang YB; Huang SM Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428 [TBL] [Abstract][Full Text] [Related]
20. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus. Phillips AO; Baboolal K; Riley S; Gröne H; Janssen U; Steadman R; Williams J; Floege J Am J Kidney Dis; 2001 Feb; 37(2):400-10. PubMed ID: 11157383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]